drugset / Trial / NCT01350635
Skin Test Study of BM32
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The aim of the present skin test study CS-BM32-001 is to evaluate whether the BM32 proteins exhibit low/no allergenic activity when applied by skin prick- and atopy patch testing to grass pollen allergic patients
Timeline
- Start
- 2011-05
- Primary completion
- 2011-07
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BM32 | Vaccine | 11 ug/ml | Other |
| Subject | BM32 | Vaccine | 33 ug/ml | Other |
| Subject | BM32 | Vaccine | 100 ug/ml | Other |